Furthest along
3 approved
2 in Phase 2
Drugs
10
in active trials · 19 in all
Trials
14 active
35 since 2021
Drugs10
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Tyrosine kinase inhibitor |
Approved in China | 30 Apr 2028Phase 3 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | 30 Apr 2028 · Phase 3 trial completes | ||||
| Also tested for | Non-Small Cell Lung Cancer、EGFR Sensitive Mutation, Non-Small Cell Lung Cancer and 6 more | ||||
| Open drug page | |||||
Tyrosine kinase inhibitor |
Approved in China | 30 Apr 2028Phase 3 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | 30 Apr 2028 · Phase 3 trial completes | ||||
| Also tested for | Non-Small Cell Lung Cancer, EGFR Sensitive Mutation and 1 more | ||||
| Open drug page | |||||
ALK inhibitor |
Xcovery |
Approved | 1 Feb 2029Phase 1/2 trial completes | ||
| Next date | 1 Feb 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Non-small Cell Lung Cancer, Solid Advanced Tumor | ||||
| Open drug page | |||||
— |
Phase 2 | 30 Apr 2028Phase 1/2 trial completes | |||
| Next date | 30 Apr 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Non-Small Cell Lung Cancer, Solid Tumor and 4 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 28 Dec 2028Phase 1/2 trial completes | |||
| Next date | 28 Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2026Phase 1 trial completes | |||
| Next date | Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Lymphoma and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | Jan 2027Phase 1 trial completes | |||
| Next date | Jan 2027 · Phase 1 trial completes | ||||
| Also tested for | DDI (Drug-Drug Interaction) | ||||
| Open drug page | |||||
— |
Phase 1 | Jun 2027Phase 1 trial completes | |||
| Next date | Jun 2027 · Phase 1 trial completes | ||||
| Also tested for | Non-Small Cell Lung Cancer With EGFR Mutation | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Solid Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
No drugs match “”.
About
- No active trial
- 9 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021